AHA Coding Clinic® for HCPCS - 2015 Quarter 1; FOR YOUR INFORMATION
New HCPCS J codes
There were a few new HCPCS J codes created for certain drugs which became effective for reporting purposes January 1, 2015. HCPCS J codes include drugs that ordinarily cannot be self-administered, chemotherapy drugs, immunosuppressive drugs, inhalation solutions, and other miscellaneous drugs and solutions. For a listing of the new HCPCS J codes see table on Page 6. New HCPCS J Code Code Descriptor J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) J0571 Buprenorphine, oral, 1mg J0572 Buprenorphine/naloxone, oral, less than or equal to 3 mg J0573 Buprenorphine/naloxone, oral, greater than 3 mg...
Subscribe or sign in to view the full article.
Article Overview
This page provides a concise update on newly created HCPCS Level II J codes for drugs and related products, with a table of the added identifiers and their effective reporting date. It is useful for coders, billers, compliance staff, and reimbursement teams who track drug-code updates and need to know which new J codes were introduced in this cycle.
Why This Topic Matters
Keeping drug-related HCPCS updates current helps support accurate claims reporting and timely adoption of newly issued identifiers.
What You Will Learn
- Which HCPCS Level II J code additions are included in this update
- The general categories of drugs and products covered by the new codes
- The effective reporting date associated with the update
- How the article is organized around a table of newly created identifiers
Who Should Read This
- Medical coders
- Billers
- Revenue cycle staff
- Compliance professionals
- Payers
- Pharmacy billing staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com